{"id":11217,"date":"2025-07-27T05:58:04","date_gmt":"2025-07-27T03:58:04","guid":{"rendered":"https:\/\/valintermed.com\/?p=11217"},"modified":"2025-07-27T05:58:04","modified_gmt":"2025-07-27T03:58:04","slug":"semeynaya-paroksizmalnaya-nekinezigennaya-diskineziya","status":"publish","type":"post","link":"https:\/\/valintermed.com\/en\/medlibrary\/family-paroxysmal-non-kinesigenic-dyskinesia\/","title":{"rendered":"Familial paroxysmal nonkinesigenic dyskinesia"},"content":{"rendered":"<div class=\"fpm_start\"><\/div>\n<p>Familial paroxysmal non-kinesigenic dyskinesia (FPND) is a rare neurological disorder characterized by recurrent attacks of movement disorders that cannot be attributed to kinesigenic dyskinesia and are usually not triggered by external factors such as stress or physical activity. Attacks may take the form of voluntary movement disorders, including involuntary muscle contractions and atonia, which interferes with daily functioning. These attacks often occur periodically and can last from a few seconds to several minutes. The neurological mechanisms underlying this condition remain poorly understood, making the diagnosis and treatment of FPND relevant and challenging tasks in the field of neurology.<\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_85 counter-flat ez-toc-counter ez-toc-light-blue ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title\" style=\"cursor:inherit\">Content<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewbox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewbox=\"0 0 24 24\" version=\"1.2\" baseprofile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 eztoc-toggle-hide-by-default' ><li class='ez-toc-page-1'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/valintermed.com\/en\/medlibrary\/family-paroxysmal-non-kinesigenic-dyskinesia\/#%D0%98%D1%81%D1%82%D0%BE%D1%80%D0%B8%D1%8F_%D0%B7%D0%B0%D0%B1%D0%BE%D0%BB%D0%B5%D0%B2%D0%B0%D0%BD%D0%B8%D1%8F_%D0%B8_%D0%B8%D0%BD%D1%82%D0%B5%D1%80%D0%B5%D1%81%D0%BD%D1%8B%D0%B5_%D0%B8%D1%81%D1%82%D0%BE%D1%80%D0%B8%D1%87%D0%B5%D1%81%D0%BA%D0%B8%D0%B5_%D1%84%D0%B0%D0%BA%D1%82%D1%8B\" >History of the disease and interesting historical facts<\/a><\/li><li class='ez-toc-page-1'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/valintermed.com\/en\/medlibrary\/family-paroxysmal-non-kinesigenic-dyskinesia\/#%D0%AD%D0%BF%D0%B8%D0%B4%D0%B5%D0%BC%D0%B8%D0%BE%D0%BB%D0%BE%D0%B3%D0%B8%D1%8F\" >Epidemiology<\/a><\/li><li class='ez-toc-page-1'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/valintermed.com\/en\/medlibrary\/family-paroxysmal-non-kinesigenic-dyskinesia\/#%D0%93%D0%B5%D0%BD%D0%B5%D1%82%D0%B8%D1%87%D0%B5%D1%81%D0%BA%D0%B0%D1%8F_%D0%BF%D1%80%D0%B5%D0%B4%D1%80%D0%B0%D1%81%D0%BF%D0%BE%D0%BB%D0%BE%D0%B6%D0%B5%D0%BD%D0%BD%D0%BE%D1%81%D1%82%D1%8C_%D0%BA_%D0%B4%D0%B0%D0%BD%D0%BD%D0%BE%D0%BC%D1%83_%D0%B7%D0%B0%D0%B1%D0%BE%D0%BB%D0%B5%D0%B2%D0%B0%D0%BD%D0%B8%D1%8E\" >Genetic predisposition to this disease<\/a><\/li><li class='ez-toc-page-1'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/valintermed.com\/en\/medlibrary\/family-paroxysmal-non-kinesigenic-dyskinesia\/#%D0%A4%D0%B0%D0%BA%D1%82%D0%BE%D1%80%D1%8B_%D1%80%D0%B8%D1%81%D0%BA%D0%B0_%D0%B2%D0%BE%D0%B7%D0%BD%D0%B8%D0%BA%D0%BD%D0%BE%D0%B2%D0%B5%D0%BD%D0%B8%D1%8F_%D0%B4%D0%B0%D0%BD%D0%BD%D0%BE%D0%B3%D0%BE_%D0%B7%D0%B0%D0%B1%D0%BE%D0%BB%D0%B5%D0%B2%D0%B0%D0%BD%D0%B8%D1%8F\" >Risk factors for the development of this disease<\/a><\/li><li class='ez-toc-page-1'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/valintermed.com\/en\/medlibrary\/family-paroxysmal-non-kinesigenic-dyskinesia\/#%D0%94%D0%B8%D0%B0%D0%B3%D0%BD%D0%BE%D1%81%D1%82%D0%B8%D0%BA%D0%B0_%D0%B4%D0%B0%D0%BD%D0%BD%D0%BE%D0%B3%D0%BE_%D0%B7%D0%B0%D0%B1%D0%BE%D0%BB%D0%B5%D0%B2%D0%B0%D0%BD%D0%B8%D1%8F\" >Diagnosis of this disease<\/a><\/li><li class='ez-toc-page-1'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/valintermed.com\/en\/medlibrary\/family-paroxysmal-non-kinesigenic-dyskinesia\/#%D0%9B%D0%B5%D1%87%D0%B5%D0%BD%D0%B8%D0%B5\" >Treatment<\/a><\/li><li class='ez-toc-page-1'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/valintermed.com\/en\/medlibrary\/family-paroxysmal-non-kinesigenic-dyskinesia\/#%D0%A1%D0%BF%D0%B8%D1%81%D0%BE%D0%BA_%D0%BB%D0%B5%D0%BA%D0%B0%D1%80%D1%81%D1%82%D0%B2_%D0%BF%D1%80%D0%B8%D0%BC%D0%B5%D0%BD%D1%8F%D0%B5%D0%BC%D1%8B%D1%85_%D0%B4%D0%BB%D1%8F_%D0%BB%D0%B5%D1%87%D0%B5%D0%BD%D0%B8%D1%8F_%D0%B4%D0%B0%D0%BD%D0%BD%D0%BE%D0%B3%D0%BE_%D0%B7%D0%B0%D0%B1%D0%BE%D0%BB%D0%B5%D0%B2%D0%B0%D0%BD%D0%B8%D1%8F\" >List of drugs used to treat this disease<\/a><\/li><li class='ez-toc-page-1'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/valintermed.com\/en\/medlibrary\/family-paroxysmal-non-kinesigenic-dyskinesia\/#%D0%9C%D0%BE%D0%BD%D0%B8%D1%82%D0%BE%D1%80%D0%B8%D0%BD%D0%B3_%D0%B7%D0%B0%D0%B1%D0%BE%D0%BB%D0%B5%D0%B2%D0%B0%D0%BD%D0%B8%D1%8F\" >Disease monitoring<\/a><\/li><li class='ez-toc-page-1'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/valintermed.com\/en\/medlibrary\/family-paroxysmal-non-kinesigenic-dyskinesia\/#%D0%92%D0%BE%D0%B7%D1%80%D0%B0%D1%81%D1%82%D0%BD%D1%8B%D0%B5_%D0%BE%D1%81%D0%BE%D0%B1%D0%B5%D0%BD%D0%BD%D0%BE%D1%81%D1%82%D0%B8_%D0%B7%D0%B0%D0%B1%D0%BE%D0%BB%D0%B5%D0%B2%D0%B0%D0%BD%D0%B8%D1%8F\" >Age-related features of the disease<\/a><\/li><li class='ez-toc-page-1'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/valintermed.com\/en\/medlibrary\/family-paroxysmal-non-kinesigenic-dyskinesia\/#%D0%92%D0%BE%D0%BF%D1%80%D0%BE%D1%81%D1%8B_%D0%B8_%D0%BE%D1%82%D0%B2%D0%B5%D1%82%D1%8B\" >Questions and Answers<\/a><\/li><li class='ez-toc-page-1'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/valintermed.com\/en\/medlibrary\/family-paroxysmal-non-kinesigenic-dyskinesia\/#%D0%A1%D0%BE%D0%B2%D0%B5%D1%82%D1%8B_%D0%BE%D1%82_%D0%B4%D0%BE%D0%BA%D1%82%D0%BE%D1%80%D0%B0_%D0%9E%D0%BB%D0%B5%D0%B3%D0%B0_%D0%9A%D0%BE%D1%80%D0%B6%D0%B8%D0%BA%D0%BE%D0%B2%D0%B0\" >Advice from Dr. Oleg Korzhikov<\/a><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"%D0%98%D1%81%D1%82%D0%BE%D1%80%D0%B8%D1%8F_%D0%B7%D0%B0%D0%B1%D0%BE%D0%BB%D0%B5%D0%B2%D0%B0%D0%BD%D0%B8%D1%8F_%D0%B8_%D0%B8%D0%BD%D1%82%D0%B5%D1%80%D0%B5%D1%81%D0%BD%D1%8B%D0%B5_%D0%B8%D1%81%D1%82%D0%BE%D1%80%D0%B8%D1%87%D0%B5%D1%81%D0%BA%D0%B8%D0%B5_%D1%84%D0%B0%D0%BA%D1%82%D1%8B\"><\/span>History of the disease and interesting historical facts<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Historically, symptoms of familial paroxysmal nonkinesigenic dyskinesia have been noted in the medical literature for decades, but the term itself is a relatively recent development. The first documented cases date back to the mid-20th century, when doctors began to recognize similarities between patients&#039; symptoms and descriptions of movement disorders seen in people in family groups.<\/p>\n<p>Interestingly, in the 1980s, research by neurological groups foreshadowed a deeper understanding of the genetic nature of the disease. The discovery of a link between the occurrence of certain gene mutations and the onset of symptoms of PD played a key role in further research and diagnosis. Since then, thanks to modern genetic techniques, more than 10 known cases of familial forms of PD have been identified, emphasizing the importance of genetic counseling and early diagnosis.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"%D0%AD%D0%BF%D0%B8%D0%B4%D0%B5%D0%BC%D0%B8%D0%BE%D0%BB%D0%BE%D0%B3%D0%B8%D1%8F\"><\/span>Epidemiology<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>The epidemiology of familial paroxysmal non-kinesigenic dyskinesia is indeed challenging, as it is a rare disorder. The prevalence of FPND is estimated to be around 1-2 cases per 100,000 population, making it one of the rare movement disorders. Most cases occur in people between the ages of 10 and 30, but the disorder can occur at any age.<\/p>\n<p>Meta-analysis of data from various studies shows that among all genetic forms of dyskinesia, SPND accounts for less than 5% cases. The incidence also varies by region, racial, and ethnic groups, which may indicate the presence of specific genetic predispositions in these populations.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"%D0%93%D0%B5%D0%BD%D0%B5%D1%82%D0%B8%D1%87%D0%B5%D1%81%D0%BA%D0%B0%D1%8F_%D0%BF%D1%80%D0%B5%D0%B4%D1%80%D0%B0%D1%81%D0%BF%D0%BE%D0%BB%D0%BE%D0%B6%D0%B5%D0%BD%D0%BD%D0%BE%D1%81%D1%82%D1%8C_%D0%BA_%D0%B4%D0%B0%D0%BD%D0%BD%D0%BE%D0%BC%D1%83_%D0%B7%D0%B0%D0%B1%D0%BE%D0%BB%D0%B5%D0%B2%D0%B0%D0%BD%D0%B8%D1%8E\"><\/span>Genetic predisposition to this disease<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Studies have shown that familial paroxysmal nonkinesigenic dyskinesia is associated with mutations in the PRRT2 gene, located on chromosome 16. More than 50% cases of the disease have this genetic abnormality as their basis. Mutations in this gene affect the functional structure of neurons and can interfere with normal synaptic interaction, resulting in paroxysmal events.<\/p>\n<p>Long-term genetic studies have identified other genes, such as MYO15A and KCNMA1, that may also be involved in the development of PD. Establishing a genetic predisposition allows for more targeted diagnostic and treatment strategies for patients with the condition. Research into the potential for genetic counseling also opens up new horizons in disease prevention in families with known cases of PD.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"%D0%A4%D0%B0%D0%BA%D1%82%D0%BE%D1%80%D1%8B_%D1%80%D0%B8%D1%81%D0%BA%D0%B0_%D0%B2%D0%BE%D0%B7%D0%BD%D0%B8%D0%BA%D0%BD%D0%BE%D0%B2%D0%B5%D0%BD%D0%B8%D1%8F_%D0%B4%D0%B0%D0%BD%D0%BD%D0%BE%D0%B3%D0%BE_%D0%B7%D0%B0%D0%B1%D0%BE%D0%BB%D0%B5%D0%B2%D0%B0%D0%BD%D0%B8%D1%8F\"><\/span>Risk factors for the development of this disease<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Today, risk factors for familial paroxysmal nonkinesigenic dyskinesia are a complex combination of genetic and environmental components. The main factors include:<\/p>\n<ul>\n<li><strong>Genetic predisposition:<\/strong> The presence of cases of the disease in the family significantly increases the risk of developing SPND in offspring.<\/li>\n<li><strong>Physical factors:<\/strong> Head injuries and other neurotrauma may act as catalysts for the onset of symptoms in genetically predisposed individuals.<\/li>\n<li><strong>Chemical factors:<\/strong> exposure to toxic substances or disrupted metabolic processes in the body can also be associated with manifestations of the disease.<\/li>\n<li><strong>Other factors:<\/strong> Psychological stress, infections and other neurological diseases can aggravate symptoms, but are not the primary causes.<\/li>\n<\/ul>\n<p>A sensible approach to assessing and monitoring these factors can play a key role in preventing or managing disease symptoms. <\/p><script data-noptimize=\"\" data-wpfc-render=\"false\">\nfpm_start( \"true\" );\n<\/script>\n\n<h2><span class=\"ez-toc-section\" id=\"%D0%94%D0%B8%D0%B0%D0%B3%D0%BD%D0%BE%D1%81%D1%82%D0%B8%D0%BA%D0%B0_%D0%B4%D0%B0%D0%BD%D0%BD%D0%BE%D0%B3%D0%BE_%D0%B7%D0%B0%D0%B1%D0%BE%D0%BB%D0%B5%D0%B2%D0%B0%D0%BD%D0%B8%D1%8F\"><\/span>Diagnosis of this disease<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Diagnosis of familial paroxysmal nonkinesigenic dyskinesia includes several stages. The main symptoms consist of unexpected and recurring movement disorders. To confirm the diagnosis, specialists use the following methods:<\/p>\n<ul>\n<li><strong>Laboratory tests:<\/strong> Blood tests may be performed to rule out metabolic or infectious diseases.<\/li>\n<li><strong>Radiological examinations:<\/strong> MRI and other neuroimaging techniques can help identify anatomical changes in the brain.<\/li>\n<li><strong>Other types of diagnostics:<\/strong> EEG can be used to detect epileptic activity or other problems with brain function.<\/li>\n<li><strong>Differential diagnosis:<\/strong> It is important to exclude diseases such as epilepsy, parkinsonism, other forms of dyskinesia and psychomotor disorders.<\/li>\n<\/ul>\n<p>Early detection and accurate diagnosis are critical, as misdiagnosis can lead to ineffective treatment and a deterioration in the patient&#039;s quality of life.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"%D0%9B%D0%B5%D1%87%D0%B5%D0%BD%D0%B8%D0%B5\"><\/span>Treatment<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Treatment for familial paroxysmal nonkinesigenic dyskinesia can be quite individualized. In general, approaches include:<\/p>\n<ul>\n<li><strong>General treatment:<\/strong> Maintaining a daily routine, including regular sleep and physical activity, may help manage symptoms.<\/li>\n<li><strong>Pharmacological treatment:<\/strong> The use of drugs such as carbamazepine and clonazepam can reduce the frequency and severity of attacks.<\/li>\n<li><strong>Surgical treatment:<\/strong> In rare cases, if drug therapy is ineffective, surgical intervention may be considered.<\/li>\n<li><strong>Other types of treatment:<\/strong> Physical therapy and psychological support also play an important role in the rehabilitation program.<\/li>\n<\/ul>\n<p>The effectiveness of treatment depends on individual characteristics, and each patient requires a special approach.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"%D0%A1%D0%BF%D0%B8%D1%81%D0%BE%D0%BA_%D0%BB%D0%B5%D0%BA%D0%B0%D1%80%D1%81%D1%82%D0%B2_%D0%BF%D1%80%D0%B8%D0%BC%D0%B5%D0%BD%D1%8F%D0%B5%D0%BC%D1%8B%D1%85_%D0%B4%D0%BB%D1%8F_%D0%BB%D0%B5%D1%87%D0%B5%D0%BD%D0%B8%D1%8F_%D0%B4%D0%B0%D0%BD%D0%BD%D0%BE%D0%B3%D0%BE_%D0%B7%D0%B0%D0%B1%D0%BE%D0%BB%D0%B5%D0%B2%D0%B0%D0%BD%D0%B8%D1%8F\"><\/span>List of drugs used to treat this disease<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>There are a number of medications that are used to treat familial paroxysmal nonkinesigenic dyskinesia. These include:<\/p>\n<ul>\n<li>Carbamazepine<\/li>\n<li>Clonazepam<\/li>\n<li>Dofetilide<\/li>\n<li>Gabapentin<\/li>\n<li>Pregabalin<\/li>\n<\/ul>\n<p>Each of these agents has specific mechanisms of action and side effects that should be clearly discussed with your doctor.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"%D0%9C%D0%BE%D0%BD%D0%B8%D1%82%D0%BE%D1%80%D0%B8%D0%BD%D0%B3_%D0%B7%D0%B0%D0%B1%D0%BE%D0%BB%D0%B5%D0%B2%D0%B0%D0%BD%D0%B8%D1%8F\"><\/span>Disease monitoring<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Monitoring of the condition of patients with SPND includes regular follow-up visits to a neurologist to assess the dynamics of the disease and adjust treatment. The assessment includes:<\/p>\n<ul>\n<li><strong>Control stages:<\/strong> regular check-ups to detect both improvements and deteriorations.<\/li>\n<li><strong>Forecast:<\/strong> With the right approach and choice of adequate therapy, many patients can lead a full life.<\/li>\n<li><strong>Complications:<\/strong> disturbances of the psycho-emotional state and possible disability in the absence of proper treatment.<\/li>\n<\/ul>\n<p>Trusting communication between doctor and patient is an important condition for successful disease control.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"%D0%92%D0%BE%D0%B7%D1%80%D0%B0%D1%81%D1%82%D0%BD%D1%8B%D0%B5_%D0%BE%D1%81%D0%BE%D0%B1%D0%B5%D0%BD%D0%BD%D0%BE%D1%81%D1%82%D0%B8_%D0%B7%D0%B0%D0%B1%D0%BE%D0%BB%D0%B5%D0%B2%D0%B0%D0%BD%D0%B8%D1%8F\"><\/span>Age-related features of the disease<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Familial paroxysmal nonkinesigenic dyskinesia can manifest itself at any age, but there are a number of features depending on the age group. In children, symptoms may be more pronounced in the form of attacks, while in older patients the clinical picture may be masked by other neurological disorders. <\/p>\n<p>With age, there is a possibility of an increase in concomitant diseases, which in turn can complicate the diagnosis and selection of adequate treatment. Constant monitoring of the condition of such patients is necessary to ensure timely intervention.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"%D0%92%D0%BE%D0%BF%D1%80%D0%BE%D1%81%D1%8B_%D0%B8_%D0%BE%D1%82%D0%B2%D0%B5%D1%82%D1%8B\"><\/span>Questions and Answers<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<ul>\n<li><strong>What are the main symptoms of SPND?<\/strong> The main symptoms are recurring attacks of movement disorders, involuntary muscle contractions and atony.<\/li>\n<li><strong>What diagnostic methods are used to detect SPND?<\/strong> Laboratory tests, MRI, EEG and clinical examination are used for diagnosis.<\/li>\n<li><strong>How is familial paroxysmal nonkinesigenic dyskinesia treated?<\/strong> Treatment includes medications, physical therapy and, in rare cases, surgery.<\/li>\n<li><strong>What is the genetic predisposition to SPND?<\/strong> The disease may be associated with mutations in the PRRT2 gene and other genes, which increases the risk of the disease occurring in families.<\/li>\n<li><strong>What are the risk factors for developing the disease?<\/strong> Major risk factors include genetic predisposition, head trauma, chemical exposures and psycho-emotional stress.<\/li>\n<\/ul>\n<h2><span class=\"ez-toc-section\" id=\"%D0%A1%D0%BE%D0%B2%D0%B5%D1%82%D1%8B_%D0%BE%D1%82_%D0%B4%D0%BE%D0%BA%D1%82%D0%BE%D1%80%D0%B0_%D0%9E%D0%BB%D0%B5%D0%B3%D0%B0_%D0%9A%D0%BE%D1%80%D0%B6%D0%B8%D0%BA%D0%BE%D0%B2%D0%B0\"><\/span>Advice from Dr. Oleg Korzhikov<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>I recommend that all patients with symptoms of familial paroxysmal nonkinesigenic dyskinesia make it a rule to follow a daily routine, avoid excessive stress, and exercise regularly. It is important to understand that proper treatment can significantly improve the quality of life. In addition, cooperation with a neurologist and genetic counselor will help to navigate the possibilities of treatment and rehabilitation. You should not avoid communicating with other patients, this can be beneficial for emotional health.<\/p>\n<div class=\"fpm_end\"><\/div>","protected":false},"excerpt":{"rendered":"<p>Familial paroxysmal nonkinesigenic dyskinesia (FPND) is a rare neurological disorder characterized by recurrent attacks of movement disturbances that cannot be attributed to<\/p>","protected":false},"author":1,"featured_media":18159,"comment_status":"open","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[298],"tags":[],"class_list":["post-11217","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-medlibrary"],"_links":{"self":[{"href":"https:\/\/valintermed.com\/en\/wp-json\/wp\/v2\/posts\/11217","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/valintermed.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/valintermed.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/valintermed.com\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/valintermed.com\/en\/wp-json\/wp\/v2\/comments?post=11217"}],"version-history":[{"count":1,"href":"https:\/\/valintermed.com\/en\/wp-json\/wp\/v2\/posts\/11217\/revisions"}],"predecessor-version":[{"id":15998,"href":"https:\/\/valintermed.com\/en\/wp-json\/wp\/v2\/posts\/11217\/revisions\/15998"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/valintermed.com\/en\/wp-json\/wp\/v2\/media\/18159"}],"wp:attachment":[{"href":"https:\/\/valintermed.com\/en\/wp-json\/wp\/v2\/media?parent=11217"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/valintermed.com\/en\/wp-json\/wp\/v2\/categories?post=11217"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/valintermed.com\/en\/wp-json\/wp\/v2\/tags?post=11217"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}